deferiprone has been researched along with Airflow Obstruction, Chronic in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, K | 1 |
| Zhang, WZ | 1 |
| Kikkers, SA | 1 |
| O'Beirne, SL | 1 |
| Strulovici-Barel, Y | 1 |
| Kaner, RJ | 1 |
| Crystal, RG | 1 |
| Cloonan, SM | 1 |
1 other study available for deferiprone and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Use of the Iron Chelator Deferiprone to Restore Function in BAL Fluid Macrophages in Smoking and Chronic Obstructive Pulmonary Disease.
Topics: Deferiprone; Humans; Iron; Iron Chelating Agents; Macrophages; Pulmonary Disease, Chronic Obstructiv | 2023 |